Raia Drogasil S.A. (RADLY)
| Market Cap | 6.31B +35.9% |
| Revenue (ttm) | 8.73B +16.7% |
| Net Income | 247.64M +9.9% |
| EPS | 0.15 +11.5% |
| Shares Out | n/a |
| PE Ratio | 25.47 |
| Forward PE | 18.53 |
| Dividend | 0.05 (1.42%) |
| Ex-Dividend Date | Apr 13, 2026 |
| Volume | 30 |
| Open | 3.490 |
| Previous Close | 3.670 |
| Day's Range | 3.490 - 3.490 |
| 52-Week Range | 2.167 - 5.342 |
| Beta | 0.11 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 5, 2026 |
About Raia Drogasil
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil. [Read more]
Financial Performance
In 2025, Raia Drogasil's revenue was 44.25 billion, an increase of 13.84% compared to the previous year's 38.87 billion. Earnings were 1.30 billion, an increase of 8.08%.
Financial numbers in BRL Financial StatementsNews
Raia Drogasil Earnings Call Transcript: Q1 2026
Q1 2026 saw 20% revenue growth, 70% higher net income, and strong digital expansion, with market share up 150 bps and stable margins. Efficiency gains, inventory reduction, and successful 4Bio divestment support a positive outlook despite regulatory and competitive pressures.
Raia Drogasil Earnings release: Q1 2026
Raia Drogasil released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Raia Drogasil Slides: Q1 2026
Raia Drogasil has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Raia Drogasil Earnings Call Transcript: Q4 2025
Record Q4 2025 results with 23% retail growth, 170 bps market share gain, and strong digital expansion. Strategic 4Bio sale sharpened focus on core retail, while disciplined capital allocation and operational efficiency drove margin improvements.
Raia Drogasil Earnings release: Q4 2025
Raia Drogasil released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.
Raia Drogasil Slides: Q4 2025
Raia Drogasil has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.
Raia Drogasil Slides: Investor presentation
Raia Drogasil has posted slides in relation to its latest quarterly earnings report, which was published on January 21, 2026.
Raia Drogasil Earnings Call Transcript: Q3 2025
Q3 2025 saw robust revenue and EBITDA growth, driven by strong retail and digital performance, improved cost control, and record market share. Inventory and cash cycle improvements, new distribution centers, and digital expansion position the company for continued growth.
Raia Drogasil Earnings release: Q3 2025
Raia Drogasil released its Q3 2025 earnings on November 5, 2025, summarizing the period's financial results.
Raia Drogasil Slides: Q3 2025
Raia Drogasil has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 5, 2025.
Raia Drogasil Earnings Call Transcript: Q2 2025
Strong sales and digital growth drove a 12% revenue increase and record net income, with market share gains across all regions. Inventory and expense efficiencies improved margins, while digital and retail segments both delivered robust performance.
Raia Drogasil Earnings release: Q2 2025
Raia Drogasil released its Q2 2025 earnings on August 6, 2025, summarizing the period's financial results.
Raia Drogasil Slides: Q2 2025
Raia Drogasil has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 6, 2025.